News Releases Items Per Page 102550 Year None2020201920182017201620152012 Aug 10, 2020 Galera Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates View HTML PDF Version Jul 30, 2020 Galera Therapeutics to Participate in Fireside Chat at 2020 BTIG Virtual Biotechnology Conference View HTML PDF Version Jul 13, 2020 Galera Therapeutics Completes Enrollment of Phase 1b/2a Clinical Trial of GC4419 in Combination with Radiotherapy for Locally Advanced Pancreatic Cancer View HTML PDF Version May 29, 2020 Galera Therapeutics Announces Avasopasem Manganese Improved Markers of Chronic Kidney Disease in Patients Receiving Cisplatin View HTML PDF Version May 18, 2020 Galera Therapeutics to Host Virtual KOL Event on Cisplatin-Induced Chronic Kidney Disease View HTML PDF Version May 13, 2020 Galera Therapeutics Announces New Data from the Phase 2b Trial on the Effect of Avasopasem Manganese on Cisplatin-Induced Chronic Kidney Disease to be Presented at ASCO 2020 Virtual Scientific Program View HTML PDF Version May 12, 2020 Galera Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates View HTML PDF Version May 05, 2020 Galera Therapeutics to Present at BofA Securities 2020 Health Care Conference View HTML PDF Version Apr 30, 2020 Galera Therapeutics Announces Presentation of Avasopasem Manganese Data at ASCO 2020 Virtual Scientific Program View HTML PDF Version Apr 02, 2020 Galera Therapeutics Appoints Linda B. West to Board of Directors View HTML PDF Version Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Next page next › Last page last » Displaying 11 - 20 of 25 results